News tagged with 'Johnson '

The news keeps getting worse for Johnson & Johnson and its McNeil Consumer Healthcare division. The company has announced an expanded recall for Benadryl allergy tablets and Extra Strength Tylenol gels. This is a follow-up to a January recall after consumers complained of musty or moldy odors.

The FDA needs mandatory recall authority to deal with problematic manufacturing plants such as the one that makes Children's Tylenol, lawmakers concluded at a hearing Thursday. A J & J executive told lawmakers that six key personnel have been let go and that the situation is "unacceptable" though no children have been hurt.

The head of Johnson & Johnson is expected to be present at a Thursday Congressional committee hearing to further explore manufacturing lapses at a company plant that led to a recall of 40 children's pain and allergy over-the-counter medications. Meanwhile, the FDA is trying to sort out adverse events coming into the agency from worried parents.

Johnson & Johnson is facing an expanded probe into its manufacturing practices after four recalls in seven months, the most recent at a Pennsylvania plant that makes Children's Tylenol products. The FDA tells parents to choose generics over Tylenol.

Because 212 people drank the Benadryl topical gel for itch instead of applying it topically, the package will be redesigned, announced Johnson & Johnson and the FDA today.

With promises of developing a blockbuster drug to treat 26 million Alzheimer's patients worldwide, research continues on bapineuzumab despite evidence it is not effective and may be targeting the wrong underlying cause of Alzheimer's.

Expect a round of positive PR even though McNeil's Fort Washington, Pennsylvania manufacturing plant remains closed and the source and type of contaminant of childrens over-the-counter cold and allergy meds remains a mystery.

The FDA is taking its recall of children's Tylenol products one step further and advising parents to choose generic cold medications after an inspection report of the plant reveals lapsed quality controls.

Four of five new drugs are awaiting approval by the FDA and hope to become blockbusters for their pharmaceutical drugmakers and inject new life into profits.

McNeil Consumer Healthcare makes a host of over-the-counter pain relievers and has found a chemical used to transport packing materials may have transferred to the product, creating a musty-mildew odor. Consumers should return any product listed in the recall with an odor and not take it.

Tylenol Arthritis Caplets are recalled because of some bacterial contamination. Contact Johnson & Johnson for a full refund and the FDA warns consumers not to use the product.

Talc contains tiny fibers similar to those found in asbestos that can travel from the genital area to the ovaries causing cancer. This federal lawsuit filed by a woman diagnosed with ovarian cancer, blames talc maker, Johnson & Johnson, as well as two mining companies for failing to warn the consumer.

With more than five million people in the US reportedly misusing prescription pain relievers, the FDA is asking drug makers to formulate a risk-management plan for the entire class of opioids to avoid overdose and death.

J & J won preliminary approval to market a new ceramic-on-metal hip replacement device that is thought to be an improvement over metal-on-metal.

An expert panel convened to advise the FDA on acetaminophen, voted today that  Johnson & Johnson's Tylenol be given in smaller doses and the Extra Strength Tylenol should be sold by prescription only to reduce the dangers of serious liver injury.